When we cultured NK cells from healthy individuals in vitro with HDC plus IL-2, the expansion of a CD56brightCD16neg and a CD56brightCD16low subset observed after HDC plus IL-2 treatment in AML patients could be partly mimicked. Here, IL2 is linked to acute myeloid leukemia.